Annals of the Rheumatic Diseases: 81 (3)

Editorial

Hydroxychloroquine and lupus flare: a good drug, but we need to do better (17 January, 2022) Free
Mary K Crow, Kyriakos A Kirou

Viewpoint

Time to reconsider what Global Burden of Disease studies really tell us about low back pain (28 September, 2021)
Chris Maher, Giovanni Ferreira

Criteria

2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Eosinophilic Granulomatosis with Polyangiitis (2 February, 2022)
Peter C Grayson, Cristina Ponte, Ravi Suppiah, Joanna C Robson, Anthea Craven, Andrew Judge, Sara Khalid, Andrew Hutchings, Raashid A Luqmani, Richard A Watts, Peter A Merkel
2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for granulomatosis with polyangiitis (2 February, 2022)
Joanna C Robson, Peter C Grayson, Cristina Ponte, Ravi Suppiah, Anthea Craven, Andrew Judge, Sara Khalid, Andrew Hutchings, Richard A Watts, Peter A Merkel, Raashid A Luqmani
2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for microscopic polyangiitis (2 February, 2022)
Ravi Suppiah, Joanna C Robson, Peter C Grayson, Cristina Ponte, Anthea Craven, Sara Khalid, Andrew Judge, Andrew Hutchings, Peter A Merkel, Raashid A Luqmani, Richard A Watts

Rheumatoid arthritis

Multilevel factors predict medication adherence in rheumatoid arthritis: a 6-month cohort study (29 November, 2021) Free
Alejandro Balsa, Maria Jesus García de Yébenes, Loreto Carmona
Safety of baricitinib for the treatment of rheumatoid arthritis over a median of 4.6 and up to 9.3 years of treatment: final results from long-term extension study and integrated database (27 October, 2021)
Peter C Taylor, Tsutomu Takeuchi, Gerd R Burmester, Patrick Durez, Josef S Smolen, Walter Deberdt, Maher Issa, Jorge Ross Terres, Natalia Bello, Kevin L Winthrop
Fatigue in patients with early rheumatoid arthritis undergoing treat-to-target therapy: predictors and response to treatment (13 August, 2021)
Karen Holten, Nina Paulshus Sundlisater, Siri Lillegraven, Joseph Sexton, Lena Bugge Nordberg, Ellen Moholt, Hilde Berner Hammer, Till Uhlig, Tore K Kvien, Espen A Haavardsholm, Anna-Birgitte Aga

Psoriatic arthritis

Efficacy and safety of risankizumab for active psoriatic arthritis: 24-week results from the randomised, double-blind, phase 3 KEEPsAKE 2 trial (23 November, 2021)
Andrew Östör, Filip Van den Bosch, Kim Papp, Cecilia Asnal, Ricardo Blanco, Jacob Aelion, Gabriela Alperovich, Wenjing Lu, Zailong Wang, Ahmed M Soliman, Ann Eldred, Lisa Barcomb, Alan Kivitz
Efficacy and safety of guselkumab in patients with active psoriatic arthritis who are inadequate responders to tumour necrosis factor inhibitors: results through one year of a phase IIIb, randomised, controlled study (COSMOS) (24 November, 2021)
Laura C Coates, Laure Gossec, Elke Theander, Paul Bergmans, Marlies Neuhold, Chetan S Karyekar, May Shawi, Wim Noël, Georg Schett, Iain B McInnes

Systemic lupus erythematosus

Flares after hydroxychloroquine reduction or discontinuation: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort (15 December, 2021)
Celline C Almeida-Brasil, John G Hanly, Murray Urowitz, Ann Elaine Clarke, Guillermo Ruiz-Irastorza, Caroline Gordon, Rosalind Ramsey-Goldman, Michelle Petri, Ellen M Ginzler, D J Wallace, Sang-Cheol Bae, Juanita Romero-Diaz, Mary Anne Dooley, Christine Peschken, David Isenberg, Anisur Rahman, Susan Manzi, Søren Jacobsen, Sam Lim, Ronald F van Vollenhoven, Ola Nived, Andreas Jönsen, Diane L Kamen, Cynthia Aranow, Jorge Sanchez-Guerrero, Dafna D Gladman, Paul R Fortin, Graciela S Alarcón, Joan T Merrill, Kenneth Kalunian, Manuel Ramos-Casals, Kristján Steinsson, Asad Zoma, Anca Askanase, Munther A Khamashta, Ian N Bruce, Murat Inanc, Michal Abrahamowicz, Sasha Bernatsky

Autoimmunity

Rheumatoid arthritis, systemic lupus erythematosus and primary Sjögren’s syndrome shared megakaryocyte expansion in peripheral blood (30 August, 2021)
Yukai Wang, Xuezhen Xie, Chengpeng Zhang, Miaotong Su, Sini Gao, Jing Wang, Changhao Lu, Qisheng Lin, Jianqun Lin, Marco Matucci-Cerinic, Daniel E Furst, Guohong Zhang

Behcet’s disease

A unique circulating miRNA profile highlights thrombo-inflammation in Behçet’s syndrome (29 November, 2021)
Giacomo Emmi, Giacomo Bagni, Elena Lastraioli, Francesca Di Patti, Alessandra Bettiol, Claudia Fiorillo, Matteo Becatti, Elena Silvestri, Maria Letizia Urban, Lorenzo Emmi, Domenico Prisco, Annarosa Arcangeli

Treatment

Serious infections in patients with rheumatoid arthritis and psoriatic arthritis treated with tumour necrosis factor inhibitors: data from register linkage of the NOR-DMARD study (8 October, 2021)
Ingrid Egeland Christensen, Siri Lillegraven, Pawel Mielnik, Gunnstein Bakland, Liz Loli, Joe Sexton, Till Uhlig, Tore K Kvien, Sella A Provan
Analysing cord blood levels of TNF inhibitors to validate the EULAR points to consider for TNF inhibitor use during pregnancy (7 September, 2021)
Nafise Ghalandari, Erik Kemper, Ineke (Hubertina) Crijns, Gertjan Wolbink, Theo Rispens, Hieronymus TW Smeele, Radboud JEM Dolhain
Severe delayed hypersensitivity reactions to IL-1 and IL-6 inhibitors link to common HLA-DRB1*15 alleles (17 November, 2021)
Vivian E Saper, Michael J Ombrello, Adriana H Tremoulet, Gonzalo Montero-Martin, Sampath Prahalad, Scott Canna, Chisato Shimizu, Gail Deutsch, Serena Y Tan, Elaine F Remmers, Dimitri Monos, Timothy Hahn, Omkar K Phadke, Elaine Cassidy, Ian Ferguson, Vamsee Mallajosyula, Jianpeng Xu, Jaime S Rosa Duque, Gilbert T Chua, Debopam Ghosh, Ann Marie Szymanski, Danielle Rubin, Jane C Burns, Lu Tian, Marcelo A Fernandez-Vina, Elizabeth D Mellins, Jill A Hollenbach, Drug Hypersensitivity Consortium

Epidemiology

Importance of the second SARS-CoV-2 vaccination dose for achieving serological response in patients with rheumatoid arthritis and seronegative spondyloarthritis (29 November, 2021) Free
Elisabeth Simader, Selma Tobudic, Peter Mandl, Helmuth Haslacher, Thomas Perkmann, Thomas Nothnagl, Judith Sautner, Helga Radner, Florian Winkler, Heinz Burgmann, Daniel Mrak, Daniel Aletaha, Stefan Winkler, Stephan Blüml
Risk and prognosis of SARS-CoV-2 infection and vaccination against SARS-CoV-2 in rheumatic and musculoskeletal diseases: a systematic literature review to inform EULAR recommendations (7 December, 2021) Free
Féline P B Kroon, Aurélie Najm, Alessia Alunno, Jan W Schoones, Robert B M Landewé, Pedro M Machado, Victoria Navarro-Compán
Influenza outcomes in patients with inflammatory joint diseases and DMARDs: how do they compare to those of COVID-19? (22 November, 2021) Free
Hannah Bower, Thomas Frisell, Daniela Di Giuseppe, Bénédicte Delcoigne, Johan Askling

Letters

Spectrum of short-term inflammatory musculoskeletal manifestations after COVID-19 vaccine administration: a report of 66 cases (26 November, 2021) Free
Francesco Ursini, Piero Ruscitti, Vincenzo Raimondo, Rossella De Angelis, Fabio Cacciapaglia, Erika Pigatto, Domenico Olivo, Ilenia Di Cola, Felice Galluccio, Francesca Francioso, Rosario Foti, Antonio Tavoni, Salvatore D'Angelo, Corrado Campochiaro, Francesca Motta, Maria De Santis, Silvia Bilia, Caterina Bruno, Giacomo De Luca, Marcella Visentini, Jacopo Ciaffi, Luana Mancarella, Veronica Brusi, Martina D’Onghia, Giovanna Cuomo, Enrico Fusaro, Lorenzo Dagna, Serena Guiducci, Riccardo Meliconi, Florenzo Iannone, Annamaria Iagnocco, Roberto Giacomelli, Clodoveo Ferri
Flares of mixed cryoglobulinaemia vasculitis after vaccination against SARS-CoV-2 (24 November, 2021) Free
Marcella Visentini, Laura Gragnani, Stefano Angelo Santini, Teresa Urraro, Annalisa Villa, Monica Monti, Andrea Palladino, Luisa Petraccia, Francesca La Gualana, Serena Lorini, Silvia Marri, Francesco Madia, Lucia Stefanini, Stefania Basili, Massimo Fiorilli, Clodoveo Ferri, Anna Linda Zignego, Milvia Casato
Safety and disease flare of autoimmune inflammatory rheumatic diseases: a large real-world survey on inactivated COVID-19 vaccines (25 November, 2021)
Yong Fan, Yan Geng, Yu Wang, Xuerong Deng, Guangtao Li, Juan Zhao, Lanlan Ji, Xiaohui Zhang, Zhibo Song, Haoze Zhang, Xiaoying Sun, Dai Gao, Wenhui Xie, Hong Huang, YanJie Hao, Zhuoli Zhang
Higher serum levels of short-chain fatty acids are associated with non-progression to arthritis in individuals at increased risk of RA (24 November, 2021)
Klara Martinsson, Kerstin Dürholz, Georg Schett, Mario M Zaiss, Alf Kastbom
When extended genetics rescues diagnosis: a patient with CANDLE-like phenotype and de novo mutation in the SAMD9L gene
(30 November, 2021)
Amandine Remy, Charlotte Borocco, Guillaume Sarrabay, Guilaine Boursier, Sylvie Fraitag, Benoit Catteau, Héloise Reumaux, Isabelle Koné-Paut
Challenges in optimising patient participation in research: do patients participating in meetings represent the actual patient population with Behçet’s syndrome? (26 November, 2021)
Sıtkı Safa Taflan, Sinem Nihal Esatoglu, Yesim Ozguler, Berna Yurttas, Melike Melikoglu, Gulen Hatemi

Electronic pages

Can sexual dimorphism in rheumatoid arthritis be attributed to the different abundance of Gardnerella?
(10 March, 2020) Free
Dongsong Liu, Feng Zhang, Hong Cao, Xuesong Wang
Response to: ‘Can sexual dimorphism in rheumatoid arthritis be attributed to the different abundance of Gardnerella?’ by Liu et al
(25 March, 2020) Free
Toshihiro Kishikawa, Yuichi Maeda, Takuro Nii, Yukinori Okada
Questions on ‘Sequencing of the MHC region defines HLA-DQA1 as the major genetic risk for seropositive rheumatoid arthritis in Han Chinese population’ by Guo et al
(5 February, 2020) Free
Cristina Regueiro, Antonio Gonzalez
Response to: ‘Questions on ‘Sequencing of the MHC region defines HLA-DQA1 as the major genetic risk for seropositive rheumatoid arthritis in Han Chinese population’ by Guo et al’ by Regueiro and Gonzalez
(5 May, 2020) Free
Jianping Guo, Tao Zhang, Xiaowei Li, Hongzhi Cao, Zhanguo Li
Reactive arthritis, a missing link: comment on the recent article from Sepriano et al
(25 March, 2020) Free
Henning Zeidler, Alan P Hudson
Response to: ‘Reactive arthritis, a missing link: comment on the recent article from Sepriano et al’ by Zeidler and Hudson
(2 April, 2020) Free
Alexandre Sepriano, Sofia Ramiro, Désirée van der Heijde, Robert B M Landewé
Secukinumab efficacy in patients with PsA is not dependent on patients’ body mass index (13 March, 2020) Free
Ilenia Pantano, Daniela Iacono, Ennio Giulio Favalli, Giuseppe Scalise, Luisa Costa, Francesco Caso, Giuliana Guggino, Raffaele Scarpa, Francesco Ciccia
Prevalence of comorbidities and risk factors in spondyloarthritis: results of a cross-sectional study (25 March, 2020) Free
Yupeng Lai, Yanpeng Zhang, Shaozhen Mo, Jinsheng Ma, Tongxin Ni, Zhihao Lei, Jun Xia, Chiduo Xu
Glucocorticoid withdrawal in lupus – to do or not to do? (10 March, 2020) Free
Nupoor Acharya
Response to: ‘Glucocorticoid withdrawal in lupus: to do or not to do?’ by Acharya (2 April, 2020) Free
Alexis Mathian, Micheline Pha, Zahir Amoura
Comments on the article: “Withdrawal of low-dose prednisone in SLE patients with a clinically quiescent disease for more than 1 year: a randomised clinical trial” (18 March, 2020) Free
Mohammad Reza Mousavi, Erfan Taherifard
Response to: ‘Comments on the article: "Withdrawal of low-dose prednisone in SLE patients with a clinically quiescent disease for more than 1 year: a randomised clinical trial"’ by Mousavi and Taherifard (10 April, 2020) Free
Alexis Mathian, Micheline Pha, Zahir Amoura
Immune-mediated necrotizing myopathies and interstitial lung disease are predominant characteristics in anti-Ku positive patients with idiopathic inflammatory myopathies (17 February, 2020) Free
Hongxia Yang, Wenli Li, Xiaolan Tian, Guochun Wang, Xiaoming Shu, Qinglin Peng, Xin Lu
Response to: ‘Immune-mediated necrotizing myopathies and interstitial lung disease are predominant characteristics in anti-Ku positive patients with idiopathic inflammatory myopathies’ by Yang et al
(25 March, 2020) Free
Lionel Spielmann, Benoit Nespola, Alain Meyer
Efficacy of dupilumab reveals therapeutic target for IgG4-related disease: simultaneous control of inflammation and fibrosis (7 February, 2020) Free
Motohisa Yamamoto, Noritada Yoshikawa, Hirotoshi Tanaka
MRI and ultrasonography are useful tools for a non-invasive diagnosis of IgG4-related disease (30 March, 2020) Free
Augustin Lecler, Thomas Sené
Features of polymyalgia rheumatica–like syndrome after immune checkpoint inhibitor therapy (18 March, 2020) Free
Gregoire Martin de Fremont, Rakiba Belkhir, Julien Henry, Anne Laure Voisin, Olivier Lambotte, Florent L Besson, Xavier Mariette, Gaetane Nocturne

Main menu

Table of contents

March 2022 - Volume 81 - 3

Editorial

Viewpoint

Criteria

Rheumatoid arthritis

Psoriatic arthritis

Systemic lupus erythematosus

Autoimmunity

Behcet’s disease

Treatment

Epidemiology

Letters

Electronic pages

Issue Information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Table of contents

March 2022 - Volume 81 - 3

Editorial

Viewpoint

Criteria

Rheumatoid arthritis

Psoriatic arthritis

Systemic lupus erythematosus

Autoimmunity

Behcet’s disease

Treatment

Epidemiology

Letters

Electronic pages

Issue Information